Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells

Olivier De Henau, Matthew P Rausch, David Alan Winkler, Luís Felipe Campesato, Cailian Liu, Daniel Hirschhorn-Cymerman, Sadna Budhu, Arnab Ghosh, Melissa M. Pink, Jeremy H. Tchaicha, Mark Douglas, Thomas T. Tibbitts, Sujata Pandit Sharma, Jennifer Proctor, Nicole Kosmider, Kerry White, Howard Marvin Stern, John R. Soglia, Julian Adams, Vito J. Palombella, Karen McGovern, Jeffery Lorne Kutok, Jedd D. Wolchok, Taha Merghoub

View at source ↗Article868 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/nature20554
Published
Nov 1, 2016
Venue
Nature
DOI
10.1038/nature20554
PubMed
27828943
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics